The Targeted Sequencing and Resequencing Market is witnessing significant growth and is poised for substantial expansion in the forecast years. In 2022, the market size was valued at US$ 5.1 billion, and it is expected to grow at a robust CAGR of 21% from 2023 to 2029, reaching a market size of approximately US$ 19.3 billion by 2029.
Targeted Sequencing and Resequencing Market Overview:
This Targeted Sequencing and Resequencing Market study looks at current and emerging industry trends and dynamics in the global Targeted Sequencing and Resequencing Market. Targeted Sequencing and Resequencing Extensive Market forecasting for the major Market segments is carried out between 2021 and 2027. Extensive Targeted Sequencing and Resequencing Market analysis is carried out by closely monitoring key product positions and the main competitors in the Market framework. To understand the competitive landscape of the worldwide Targeted Sequencing and Resequencing Market, key players are profiled and their strategies are thoroughly evaluated.
Do you have any questions? Ask our experts:https://www.maximizemarketresearch.com/inquiry-before-buying/190446
Market Scope:
The analysis contains a current examination of the present Targeted Sequencing and Resequencing Market landscape, as well as the most recent trends and drivers, as well as an overview of the entire Targeted Sequencing and Resequencing Market environment. Increased demand for Targeted Sequencing and Resequencing is driving the Market. The Market research examines the technology, end-user, and type categories, among other things, as well as the geographical landscape.
Request for a Sample Report to get a more detailed analysis of the other segments:https://www.maximizemarketresearch.com/request-sample/190446
Segmentation:
The market is segmented by product into three groups: instruments, reagents and consumables, and software and services. Targeted sequencing and resequencing operations need the use of instruments, including as sequencing platforms and sample preparation systems. The numerous kits, enzymes, and buffers needed for DNA sequencing reactions are included in reagents and consumables. Software and services include data analysis platforms, sequencing services, and bioinformatics tools that support the interpretation and analysis of genetic data.
The market for targeted sequencing and resequencing can be divided into categories based on their applications, including oncology, genetic testing, infectious diseases, agricultural and animal research, and others. Targeted sequencing and resequencing techniques are widely utilised in oncology to identify cancer-related genetic alterations and develop individualised treatment plans, making oncology a key application field. Applications for genetic testing and screening include the detection of hereditary disorders, carrier screening, and prenatal testing. Targeted sequencing is a method that can be used to monitor and characterise infectious diseases, such as viral epidemics.
Hospitals and clinics, pharmaceutical and biotechnology firms, academic and research institutions, and other organisations are included in the end-user segment. Academic and research institutions constantly engage in genetic research and development, which is essential for market growth. Targeted sequencing and resequencing are used by pharmaceutical and biotechnology businesses for drug development, clinical trials, and precision medicine. These methods are being used more frequently in hospitals and clinics for diagnostic procedures and individualised treatment plans.
1. Targeted Sequencing And Resequencing Market, By Product (2022-2029)
1. Kits and Reagents
2. Instruments
3. Software and Services
2. By Geography
1. North America
2. Europe
3. Asia Pacific
4. Latin America
5. Middle East and Africa
2. Targeted Sequencing And Resequencing Market, By Application(2022-2029)
6. Oncology
7. Infectious Disorder
8. Genetic Disorder
9. Other Applications
Key Players:
The Market research report provides comprehensive quantitative insights that provide a clear picture of the worldwide Market potential in a variety of categories, as well as country-by-country analyses in each covered topic. The analysis investigates the Market’s major influencing factors, as well as complete company profiles of
1. Illumina, Inc. (North America)
2. Thermo Fisher Scientific, Inc. (North America)
3. Pacific Biosciences of California, Inc. (North America)
4. Oxford Nanopore Technologies Ltd. (Europe)
5. Agilent Technologies, Inc. (North America)
6. Qiagen N.V. (Europe)
7. F. Hoffmann-La Roche Ltd (Europe)
8. PerkinElmer, Inc. (North America)
9. BGI Genomics Co., Ltd. (Asia-Pacific)
10. Genewiz (North America)
11. Eurofins Scientific (Europe)
12. Fluidigm Corporation (North America)
13. ZS Genetics, Inc. (North America)
14. ArcherDX, Inc. (North America)
15. 10x Genomics, Inc. (North America)
16. Swift Biosciences, Inc. (North America)
17. Macrogen, Inc. (Asia-Pacific)
18. GENEWIZ Germany GmbH (Europe)
19. Roche Sequencing Solutions, Inc. (North America)
20. PierianDx (North America)
21. MGI Tech Co., Ltd. (Asia-Pacific)
22. GATC Biotech AG (Europe)
23. Myriad Genetics, Inc. (North America)
24. Novogene Corporation (Asia-Pacific)
25. Agendia NV (Europe)
Regional Analysis:
Individual Market influencing variables and changes in Market laws that impact present and future Market trends are also included in the regional segment of the Market study. Data points such as downstream and upstream value chain analysis, technology trends, porter’s five forces analysis, and case studies are just a few of the indicators utilized to anticipate Market scenarios for various industries. When examining projection data for the region, the existence and availability of global players, as well as the obstacles they face as a result of substantial or low to none competition from local and domestic brands, are all taken into account.
Do You Have Any Questions About This Report? Please Contact Us On link:https://www.maximizemarketresearch.com/inquiry-before-buying/190446
COVID-19 Impact Analysis on Targeted Sequencing and Resequencing Market:
The COVID-19 epidemic has had a significant impact on the global Targeted Sequencing and Resequencing industry. Targeted Sequencing and Resequencing Production facilities were halted due to the global economic slump and a lack of manpower. The COVID-19 pandemic has led to a significant and extended drop in production utilization, and travel prohibitions and facility closures have kept personnel away from their facilities, causing the Market to decelerate in 2020. The negative impact of COVID-19 on the Market, on the other hand, is expected to be transitory, and the sector is expected to revive significantly by early 2021, owing to increased demand for Targeted Sequencing and Resequencing.
Key Questions Answered in the Targeted Sequencing and Resequencing Market Report are:
- Which segment was responsible for the largest share in the Targeted Sequencing and Resequencing Market?
- How was the competitive scenario of the Market in 2020?
- Which are the key factors responsible for the Market growth?
- Which region held the maximum share in the Targeted Sequencing and Resequencing Market in 2020?
About Maximize Market Research:
Maximize Market Research is a multifaceted Market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide Market-verified industry estimations, technical trend analysis, crucial Market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
Contact Maximize Market Research:
- MAXIMIZE MARKET RESEARCH PVT. LTD.
• ⮝444 West Lake Street, Floor 17,
• Chicago, IL, 60606, USA.
• ✆+1 800 507 4489
• ✆+91 9607365656
• 🖂[email protected]
